ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1234 participants.
Also called NCT05172960
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,234 participants
- Sponsor
- Registry
-
NCT05172960
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Canada, New Zealand
- Registry status
- Recruiting
Technical summary
Registry record NCT05172960. Non-randomized; no masking; primary purpose treatment. Start 2022-06-20 (actual); primary completion 2027-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
- Condition
- Aortic Stenosis, Severe
- Intervention (Device)
- SAPIEN X4 THV
- Intervention (Device)
- SAPIEN X4S
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct05172960- Content hash
f1ca350104882538da210640f0a9577e478b969a3cd5a7e0738decd330abba14